CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT BOTH (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED TEXT OMITTED FROM THIS EXHIBIT IS MARKED WITH [***] License & Supply Agreement KYE...License & Supply Agreement • August 20th, 2020 • Catalyst Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS LICENSE & SUPPLY AGREEMENT is made as of 14th August 2020 (“Effective Date”) by and between KYE Pharmaceuticals Inc., 2233 Argentia Road Suite 302 and 302A, Mississauga Ontario Canada L5N 2X7 Canada, a corporation incorporated under the laws of Ontario, Canada (“KYE”) and Catalyst Pharmaceuticals, Inc., 355 Alhambra Circle, Suite 1250 Coral Gables, Florida (“CATALYST”) a corporation incorporated under the laws of the state of Florida, United States of America.
